Replies to post #17768 on Kiwa Bio-Tech Products Group Corp (fka KWBT)

[edwardport]

kwbt stock price analysis - it is not good for shareholders

kwbt has raised money in past 12 months through convertible notes - once 300m A/S gets issued kwbt would effectively have raised a small amount $$$ at ($0.007) per share by selling 280,000,000 shares

now all investors on this board should understand why kwbt has under-performed the market compared to the NYSE and Nasdaq that are currently trading at all time highs

take a look at kwbt 6 month stock chart and you will see since october 2019 it has been very ugly

penny stocks can be risky and kwbt proves that to be very true

one would think CFO Hon Man Yun should be REPLACED immediately for his lack of ability to raise traditional capital

[Stockz12345]

I guess you can’t read, never said reverse at 180mill that would be dumb, I said reverse after they MAX out the O/S.... smh learn how to read before even trying bud,
And again if u can’t read I’ll say it again they just did the same thing in 2016 when the A/S was 400 mill, not that different from now..